Boston Scientific (BSX) ROE: History & Chart

Boston Scientific Corporation(BSX)

Medical - Devices · Marlborough, MA

$43.93-1.12 (-2.49%)

Delayed quote: Sep 15, 2026, 10:45 AM EDT

About Boston Scientific Corporation

Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA

59,000 employees

www.bostonscientific.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Michael F. Mahoney

View full financials

BSX Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

14.71%

RETURN ON EQUITY (ROE) AVG TTM

12.69%

RETURN ON EQUITY (ROE) AVG 3Y

9.80%

RETURN ON EQUITY (ROE) AVG 5Y

7.92%

RETURN ON EQUITY (ROE) AVG 10Y

7.88%

RETURN ON EQUITY (ROE) AVG 15Y

5.97%

RETURN ON EQUITY (ROE) AVG 20Y

3.93%

CURRENT VS TTM AVG

+15.91%

CURRENT VS 3Y AVG

+50.11%

CURRENT VS 5Y AVG

+85.75%

CURRENT VS 10Y AVG

+86.63%

CURRENT VS 15Y AVG

+146.52%

CURRENT VS 20Y AVG

+274.02%

SECTOR MEDIAN · HEALTHCARE

13.01%

median of 84 covered companies

CURRENT VS SECTOR MEDIAN

+13.06%

vs the sector median at left

NAME	MARKET CAP	RETURN ON EQUITY (ROE)	TTM	3Y	5Y
Boston Scientific Corporation (BSX)	$65.30B	14.71%	12.69%	9.80%	7.92%
Cencora, Inc. (COR)vs ›	$62.86B	86.03%	168.34%	-32.99%	148.52%
Moderna, Inc. (MRNA)vs ›	$56.82B	-46.61%	-32.64%	-13.90%	0.25%
Cardinal Health, Inc. (CAH)vs ›	$54.75B	N/A	-57.79%	-38.31%	2.19%
Cigna Corporation (CI)vs ›	$76.30B	15.05%	11.32%	12.19%	12.83%
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$80.11B	13.65%	14.72%	15.95%	23.11%
Becton, Dickinson and Company (BDX)vs ›	$50.37B	3.85%	6.60%	6.50%	6.42%
Edwards Lifesciences Corporation (EW)vs ›	$49.18B	9.46%	26.07%	24.86%	23.86%
Humana Inc. (HUM)vs ›	$47.79B	6.65%	7.05%	11.93%	15.09%
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$44.72B	9.10%	-6.34%	-12.86%	-14.53%

NAME

MARKET CAP

RETURN ON EQUITY (ROE)

TTM

Boston Scientific Corporation (BSX)

$65.30B

14.71%

12.69%

9.80%

7.92%

Cencora, Inc. (COR)vs ›

$62.86B

86.03%

168.34%

-32.99%

148.52%

Moderna, Inc. (MRNA)vs ›

$56.82B

-46.61%

-32.64%

-13.90%

0.25%

Cardinal Health, Inc. (CAH)vs ›

$54.75B

N/A

-57.79%

-38.31%

2.19%

Cigna Corporation (CI)vs ›

$76.30B

15.05%

11.32%

12.19%

12.83%

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$80.11B

13.65%

14.72%

15.95%

23.11%

Becton, Dickinson and Company (BDX)vs ›

$50.37B

3.85%

6.60%

6.50%

6.42%

Edwards Lifesciences Corporation (EW)vs ›

$49.18B

9.46%

26.07%

24.86%

23.86%

Humana Inc. (HUM)vs ›

$47.79B

6.65%

7.05%

11.93%

15.09%

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$44.72B

9.10%

-6.34%

-12.86%

-14.53%

Return on Equity (ROE) FAQ

What is the return on equity (ROE) for Boston Scientific Corporation (BSX)?

The return on equity (ROE) for BSX stock is 14.71%.

Is Boston Scientific Corporation's return on equity (ROE) high or low?

The return on equity (ROE) of 14.71% is 86% above its 5-year average of 7.92%, near the high end of its 5-year range (3.29%–14.71%).

What is the TTM average return on equity (ROE) for Boston Scientific Corporation (BSX)?

The TTM average return on equity (ROE) for BSX stock is 12.69%.

What is the 3Y average return on equity (ROE) for Boston Scientific Corporation (BSX)?

The 3Y average return on equity (ROE) for BSX stock is 9.80%.

What is the 5Y average return on equity (ROE) for Boston Scientific Corporation (BSX)?

The 5Y average return on equity (ROE) for BSX stock is 7.92%.

What is the 10Y average return on equity (ROE) for Boston Scientific Corporation (BSX)?

The 10Y average return on equity (ROE) for BSX stock is 7.88%.

What is the 15Y average return on equity (ROE) for Boston Scientific Corporation (BSX)?

The 15Y average return on equity (ROE) for BSX stock is 5.97%.

What is the 20Y average return on equity (ROE) for Boston Scientific Corporation (BSX)?

The 20Y average return on equity (ROE) for BSX stock is 3.93%.

DATE	RETURN ON EQUITY (ROE)
2026-06-30	14.71%
2026-03-31	13.74%
2025-12-31	11.93%
2025-09-30	11.92%
2025-06-30	11.16%
2025-03-31	9.15%
2024-12-31	8.51%
2024-09-30	8.65%
2024-06-30	8.96%
2024-03-31	8.89%
2023-12-31	8.26%
2023-09-30	6.50%
2023-06-30	5.00%
2023-03-31	5.05%
2022-12-31	3.98%
2022-09-30	3.70%
2022-06-30	5.12%
2022-03-31	4.84%
2021-12-31	6.26%
2021-09-30	6.67%
2021-06-30	3.29%
2021-03-31	1.22%
2020-12-31	-0.91%
2020-09-30	23.80%
2020-06-30	25.53%
2020-03-31	31.06%
2019-12-31	33.87%
2019-09-30	11.24%
2019-06-30	14.81%
2019-03-31	19.46%
2018-12-31	19.15%
2018-09-30	8.08%
2018-06-30	6.73%
2018-03-31	1.59%
2017-12-31	1.48%
2017-09-30	11.11%
2017-06-30	10.89%
2017-03-31	6.17%
2016-12-31	5.15%
2016-09-30	1.25%
2016-06-30	-5.55%
2016-03-31	-0.56%
2015-12-31	-3.78%
2015-09-30	-0.16%
2015-06-30	3.51%
2015-03-31	2.05%
2014-12-31	3.90%
2014-09-30	4.30%
2014-06-30	3.67%
2014-03-31	5.60%
2013-12-31	-1.85%
2013-09-30	-2.56%
2013-06-30	-13.45%
2013-03-31	-68.00%
2012-12-31	-57.57%
2012-09-30	-57.77%
2012-06-30	-38.50%
2012-03-31	4.46%
2011-12-31	3.66%
2011-09-30	4.72%
2011-06-30	5.13%
2011-03-31	4.80%
2010-12-31	-9.43%
2010-09-30	-21.53%
2010-06-30	-21.73%
2010-03-31	-21.40%
2009-12-31	-5.94%
2009-09-30	-15.08%
2009-06-30	-17.23%
2009-03-31	-17.86%
2008-12-31	-15.45%
2008-09-30	-0.64%
2008-06-30	-1.98%
2008-03-31	-1.90%
2007-12-31	-3.28%
2007-09-30	1.55%
2007-06-30	3.72%
2007-03-31	-24.37%
2006-12-31	-23.38%
2006-09-30	-23.44%
2006-06-30	-25.96%
2006-03-31	12.89%
2005-12-31	14.67%
2005-09-30	15.15%
2005-06-30	26.51%
2005-03-31	27.93%
2004-12-31	26.39%
2004-09-30	22.52%
2004-06-30	20.73%
2004-03-31	17.68%
2003-12-31	16.49%
2003-09-30	17.09%
2003-06-30	17.99%

DATE

RETURN ON EQUITY (ROE)

2026-06-30

14.71%

2026-03-31

13.74%

2025-12-31

11.93%

2025-09-30

11.92%

2025-06-30

11.16%

2025-03-31

9.15%

2024-12-31

8.51%

2024-09-30

8.65%

2024-06-30

8.96%

2024-03-31

8.89%

2023-12-31

8.26%

2023-09-30

6.50%

2023-06-30

5.00%

2023-03-31

5.05%

2022-12-31

3.98%

2022-09-30

3.70%

2022-06-30

5.12%

2022-03-31

4.84%

2021-12-31

6.26%

2021-09-30

6.67%

2021-06-30

3.29%

2021-03-31

1.22%

2020-12-31

-0.91%

2020-09-30

23.80%

2020-06-30

25.53%

2020-03-31

31.06%

2019-12-31

33.87%

2019-09-30

11.24%

2019-06-30

14.81%

2019-03-31

19.46%

2018-12-31

19.15%

2018-09-30

8.08%

2018-06-30

6.73%

2018-03-31

1.59%

2017-12-31

1.48%

2017-09-30

11.11%

2017-06-30

10.89%

2017-03-31

6.17%

2016-12-31

5.15%

2016-09-30

1.25%

2016-06-30

-5.55%

2016-03-31

-0.56%

2015-12-31

-3.78%

2015-09-30

-0.16%

2015-06-30

3.51%

2015-03-31

2.05%

2014-12-31

3.90%

2014-09-30

4.30%

2014-06-30

3.67%

2014-03-31

5.60%

2013-12-31

-1.85%

2013-09-30

-2.56%

2013-06-30

-13.45%

2013-03-31

-68.00%

2012-12-31

-57.57%

2012-09-30

-57.77%

2012-06-30

-38.50%

2012-03-31

4.46%

2011-12-31

3.66%

2011-09-30

4.72%

2011-06-30

5.13%

2011-03-31

4.80%

2010-12-31

-9.43%

2010-09-30

-21.53%

2010-06-30

-21.73%

2010-03-31

-21.40%

2009-12-31

-5.94%

2009-09-30

-15.08%

2009-06-30

-17.23%

2009-03-31

-17.86%

2008-12-31

-15.45%

2008-09-30

-0.64%

2008-06-30

-1.98%

2008-03-31

-1.90%

2007-12-31

-3.28%

2007-09-30

1.55%

2007-06-30

3.72%

2007-03-31

-24.37%

2006-12-31

-23.38%

2006-09-30

-23.44%

2006-06-30

-25.96%

2006-03-31

12.89%

2005-12-31

14.67%

2005-09-30

15.15%

2005-06-30

26.51%

2005-03-31

27.93%

2004-12-31

26.39%

2004-09-30

22.52%

2004-06-30

20.73%

2004-03-31

17.68%

2003-12-31

16.49%

2003-09-30

17.09%

2003-06-30

17.99%

Return on Equity (ROE): 14.71%

BSX Return on Equity (ROE)

BSX Average Return on Equity (ROE) Chart

BSX Current vs Average Return on Equity (ROE) Chart

BSX Return on Equity (ROE) Metrics

BSX Competitors' Return on Equity (ROE)

Return Analysis

Return on Equity (ROE) Formula & Definition

Return on Equity (ROE) FAQ

BSX Return on Equity (ROE) History

Related Metrics